Effects of Isoflavone Supplementation on the Response to Medroxyprogesterone in Premenopausal Women with Nonatypical Endometrial Hyperplasia: A Randomized, Double-Blind, Placebo-Controlled Trial

Table 3

Drug side effects in two intervention groups.

	Placebo group (n = 45)	Isoflavone group (n = 43)
Anorexia	7 (15.6)	5 (11.6)	0.59
Dizziness	3 (6.7)	2 (4.7)	0.68
Edema	1 (2.2)	1 (2.2)	0.97
Mastalgia	5 (11.1)	3 (7)	0.71
Abdominal pain	1 (2.2)	0	0.32
Weakness	4 (8.9)	6 (14)	0.45

Data are presented as numbers (%). ^aObtained from the chi-square test.